A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 160 participants.
Also called NCT02081690
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT02081690
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- France, Italy, Spain
- Registry status
- Terminated
Technical summary
Registry record NCT02081690. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03-01 (actual); primary completion 2015-10-01 (actual). Results posted on 2018-02-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
- Acronym
- ORCHESTRA
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- Macitentan
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct02081690- Content hash
df5f53653e80655e8cc32a5e1f6a9ea30c027a189f069f034c8d3097553f198a